Vibration Response Imaging (VRI) in Patients Who Are Potential Candidates for Surgical Resection
- Conditions
- Lung Cancer
- Interventions
- Procedure: Lung resection surgery
- Registration Number
- NCT00966511
- Lead Sponsor
- Deep Breeze
- Brief Summary
The primary purpose of the study is to investigate the use of VRI to guide the selection of patients for lung surgery. Perfusion scintigraphy is the current method to assess the fractional contribution of lung function of the remaining lung.
The hypothesis is that VRI can determine quantitative postoperative lung function equally accurately as a quantitative perfusion scan.
- Detailed Description
Primarily, VRI will be compared to perfusion (Q) scan by predicted post-operative (ppo) FEV1 and DLCO as predicted by VRI versus as predicted by Q scan. Secondary, the ppo as predicted by each test will be compared with the actual FEV1 and DLCO at 3 months post-operative; If these two methods provide similar results, VRI will be deemed an acceptable alternative to Q scan for determining patient selection for lung resection. Finally, the patient outcomes (30 day mortality and pulmonary complications) for those patients falling within guideline parameters using the VRI measurement will be analyzed to see if using VRI in clinical practice would indeed allow prediction of satisfactory results (similar to literature benchmarks).
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
- Able and willing to read, understand, and provide written Informed Consent;
- Age range of 18-90 years;
- Potential candidate for at least lobectomy due to lung cancer or other intrathoracic malignancy (either suspected or proven by biopsy). Both open and minimally invasive (thoracoscopic) resections are acceptable.
- BMI > 19.
- Body habitus or skin condition that might prevent the placement of the sound sensors on the back (e.g. severe scoliosis, kyphosis, chest wall deformation, skin lesion on the back or compression fracture);
- There should be no active pulmonary infection (e.g. pneumonia) at the time of the recordings;
- Hirsutism unless patient is willing to have back shaved;
- Potentially contagious skin lesion on the back;
- Giant bulla (more than 1/3 of the hemithorax or >10cm)
- Pregnant women
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Lung resection candidates Lung resection surgery Study participants will be patients who are candidates for lung resection (lobectomy or greater)
- Primary Outcome Measures
Name Time Method Comparison of ppo FEV1 and ppo DLCO as predicted by VRI with the values as predicted by Q scan Prior to surgery
- Secondary Outcome Measures
Name Time Method Comparison of ppo as predicted by each test with the actual FEV1 and DLCO at 3 months post-operative 3 months after surgery
Trial Locations
- Locations (6)
Yale University School of Medicine
🇺🇸New Haven, Connecticut, United States
Mt. Sinai School of Medicine
🇺🇸New York, New York, United States
Emory University
🇺🇸Atlanta, Georgia, United States
Boston Medical Center, Boston University
🇺🇸Boston, Massachusetts, United States
New York-Presbyterian Hospital/Columbia University Medical Center
🇺🇸New York, New York, United States
The University of Texas MD Anderson Cancer Center
🇺🇸Houston, Texas, United States